tradingkey.logo
tradingkey.logo
Pesquisar

Zymeworks Inc

ZYME
Adicionar à lista de desejos
26.240USD
-0.230-0.87%
Fechamento 11-13 16:00(ET)
1.85BValor de mercado
PerdaP/L TTM

Sobre o Zymeworks Inc Empresa

Zymeworks Inc. is a global clinical-stage biotechnology company. The Company is developing a diverse pipeline of multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases such as cancer, autoimmune and inflammatory diseases (AIID). The Company engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Company’s Azymetric technology. It has entered into separate agreements with BeiGene, Ltd. and Jazz Pharmaceuticals Ireland Limited, granting each exclusive rights to develop and commercialize zanidatamab in different territories. It is advancing a pipeline of wholly-owned product candidates, leveraging its expertise in both antibody-drug conjugates and multispecific antibody therapeutics targeting novel pathways in areas of significant unmet medical need. The Company has two clinical-stage product candidates: ZW171 and ZW191. Its preclinical product candidates include ZW251, ZW220, ZW209, and ZW1528.

Zymeworks Inc Perfil

Código da empresaZYME
Nome da EmpresaZymeworks Inc
Data de listagemJun 24, 2019
CEOGalbraith (Kenneth H)
Número de funcionários280
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 24
Endereço108 Patriot Drive, Suite A
CidadeMIDDLETOWN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal19709
Telefone13022748744
Sitehttps://www.zymeworks.com/
Código da empresaZYME
Data de listagemJun 24, 2019
CEOGalbraith (Kenneth H)

Executivos da empresa Zymeworks Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark Hollywood
Mr. Mark Hollywood
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
133.85K
+0.70%
Mr. Gregory A. (Greg) Ciongoli
Mr. Gregory A. (Greg) Ciongoli
Independent Director
Independent Director
--
--
Ms. Suzanne Monahan
Ms. Suzanne Monahan
Senior Vice President, General Manager - Theravance Biopharma
Senior Vice President, General Manager - Theravance Biopharma
--
--
Ms. Kristin Stafford
Ms. Kristin Stafford
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Lindsey Foulkes
Dr. Lindsey Foulkes
Senior Vice President - Corporate Development and Strategy
Senior Vice President - Corporate Development and Strategy
--
--
Ms. Bijal Desai
Ms. Bijal Desai
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Ms. Laura O'Connor
Ms. Laura O'Connor
Senior Vice President, Chief Human Resources Officer
Senior Vice President, Chief Human Resources Officer
--
--
Dr. Sabeen Mekan
Dr. Sabeen Mekan
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
--
Mr. Brian N. Cherry
Mr. Brian N. Cherry
Director
Director
--
--
Mr. Robert E. (Bob) Landry
Mr. Robert E. (Bob) Landry
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark Hollywood
Mr. Mark Hollywood
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
133.85K
+0.70%
Mr. Gregory A. (Greg) Ciongoli
Mr. Gregory A. (Greg) Ciongoli
Independent Director
Independent Director
--
--
Ms. Suzanne Monahan
Ms. Suzanne Monahan
Senior Vice President, General Manager - Theravance Biopharma
Senior Vice President, General Manager - Theravance Biopharma
--
--
Ms. Kristin Stafford
Ms. Kristin Stafford
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Lindsey Foulkes
Dr. Lindsey Foulkes
Senior Vice President - Corporate Development and Strategy
Senior Vice President - Corporate Development and Strategy
--
--
Ms. Bijal Desai
Ms. Bijal Desai
Senior Vice President - Finance
Senior Vice President - Finance
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Zymeworks Inc?

Os cinco principais acionistas de Zymeworks Inc são: Mr. Mark Hollywood
tradingkey.logo
Aviso de risco: Nosso site e aplicativo móvel fornecem apenas informações gerais sobre determinados produtos de investimento. A Finsights não oferece, e o fornecimento de tais informações não deve ser interpretado como se a Finsights estivesse oferecendo, aconselhamento financeiro ou recomendação para qualquer produto de investimento.
Os produtos de investimento estão sujeitos a riscos significativos, incluindo a possível perda do valor investido e podem não ser adequados para todos. O desempenho passado dos produtos de investimento não é indicativo de seu desempenho futuro.
A Finsights pode permitir que anunciantes ou afiliados realizem, ou forneçam anúncios em nosso site, ou aplicativo móvel, ou em qualquer parte deles e pode ser compensada por eles com base em sua interação com os anúncios.
 © Copyright: FINSIGHTS MEDIA PTE. LTD. Todos os direitos reservados.